1,25-Dihydroxyvitamin_NN
D3_NN
receptors_NNS
in_IN
peripheral_JJ
blood_NN
mononuclear_JJ
cells_NNS
from_IN
patients_NNS
with_IN
renal_JJ
insufficiency_NN
._.

A_DT
reduced_VBN
expression_NN
of_IN
the_DT
vitamin_NN
D_NN
receptor_NN
-LRB-_-LRB-
VDR_NN
-RRB-_-RRB-
in_IN
parathyroid_JJ
glands_NNS
of_IN
uremic_JJ
animals_NNS
and_CC
humans_NNS
has_VBZ
been_VBN
observed_VBN
._.

Similar_JJ
results_NNS
have_VBP
been_VBN
obtained_VBN
by_IN
our_PRP$
own_JJ
group_NN
in_IN
peripheral_JJ
blood_NN
mononuclear_JJ
cells_NNS
-LRB-_-LRB-
PBMC_NN
-RRB-_-RRB-
from_IN
patients_NNS
with_IN
secondary_JJ
hyperparathyroidism_NN
to_TO
chronic_JJ
renal_JJ
failure_NN
._.

However_RB
,_,
the_DT
reasons_NNS
for_IN
these_DT
changes_NNS
are_VBP
not_RB
clear_JJ
._.

In_IN
the_DT
present_JJ
study_NN
,_,
we_PRP
have_VBP
investigated_VBN
the_DT
specific_JJ
uptake_NN
of_IN
-LCB-_-LRB-
3H-RCB-1_NN
,25_NN
-LRB-_-LRB-
OH_NN
-RRB-_-RRB-
2D3_NN
by_IN
PBMC_NN
of_IN
11_CD
women_NNS
with_IN
advanced_JJ
chronic_JJ
renal_JJ
failure_NN
-LRB-_-LRB-
A-CRF_NN
-RRB-_-RRB-
,_,
6_CD
women_NNS
with_IN
mild-moderate_JJ
renal_JJ
insufficiency_NN
-LRB-_-LRB-
M-CRF_NN
-RRB-_-RRB-
,_,
and_CC
23_CD
healthy_JJ
women_NNS
._.

The_DT
mean_JJ
dissociation_NN
constant_NN
-LRB-_-LRB-
KD_NN
-RRB-_-RRB-
was_VBD
similar_JJ
in_IN
both_DT
groups_NNS
of_IN
patients_NNS
and_CC
in_IN
healthy_JJ
women_NNS
-LRB-_-LRB-
A-CRF_NN
:_:
0.7_CD
+_CC
\/_CD
-_:
0.5_CD
x_CC
10_CD
-LRB-_-LRB-
-10_CD
-RRB-_-RRB-
M_NN
;_:
M-CRF_NN
:_:
1.1_CD
+_CC
\/_CD
-_:
0.9_CD
x_CC
10_CD
-LRB-_-LRB-
-10_CD
-RRB-_-RRB-
M_NN
;_:
controls_NNS
:_:
1.0_CD
+_CC
\/_CD
-_:
0.6_CD
x_CC
10_CD
-LRB-_-LRB-
-10_CD
-RRB-_-RRB-
M_NN
-RRB-_-RRB-
._.

However_RB
,_,
VDR_NN
concentration_NN
was_VBD
significantly_RB
decreased_VBN
in_IN
A-CRF_NN
-LRB-_-LRB-
0.8_CD
+_CC
\/_JJ
-_:
0.5_CD
fmol\/10_NN
7_NN
cells_NNS
vs._CC
2.3_CD
+_CC
\/_CD
-_:
0.9_CD
fmol\/10_NN
7_NN
cells_NNS
in_IN
controls_NNS
,_,
p_NN
&lt;_JJR
0.001_CD
-RRB-_-RRB-
,_,
whereas_IN
no_DT
changes_NNS
were_VBD
seen_VBN
in_IN
M-CRF_NN
-LRB-_-LRB-
1.7_CD
+_CC
\/_JJ
-_:
0.7_CD
fmol\/10_NN
7_NN
cells_NNS
vs._CC
2.3_CD
+_CC
\/_CD
-_:
0.9_CD
fmol\/10_NN
7_NN
cells_NNS
in_IN
controls_NNS
-RRB-_-RRB-
._.

No_DT
correlation_NN
was_VBD
seen_VBN
between_IN
VDR_NN
and_CC
serum_NN
calcitriol_NN
or_CC
PTH_NN
levels_NNS
,_,
when_WRB
considering_VBG
both_DT
groups_NNS
of_IN
patients_NNS
together_RB
or_CC
separately_RB
._.

Conversely_RB
,_,
a_DT
significant_JJ
negative_JJ
correlation_NN
was_VBD
found_VBN
between_IN
VDR_NN
and_CC
serum_NN
creatinine_NN
values_NNS
when_WRB
A-CRF_NN
and_CC
M-CRF_NN
were_VBD
considered_VBN
altogether_RB
-LRB-_-LRB-
r_NN
=_JJ
-0.63_CD
;_:
p_NN
&lt;_JJR
0.01_CD
-RRB-_-RRB-
._.

Treatment_NN
with_IN
two_CD
different_JJ
schedules_NNS
of_IN
oral_JJ
calcitriol_NN
-LRB-_-LRB-
five_CD
patients_NNS
with_IN
0.5_CD
microgram\/day_NNS
for_IN
1_CD
month_NN
and_CC
four_CD
patients_NNS
with_IN
2_CD
micrograms\/day_NN
for_IN
7_CD
days_NNS
-RRB-_-RRB-
did_VBD
not_RB
change_VB
VDR_NN
concentrations_NNS
._.

We_PRP
conclude_VBP
that_IN
the_DT
low_JJ
levels_NNS
of_IN
serum_NN
1,25_CD
-LRB-_-LRB-
OH_NN
-RRB-_-RRB-
2D3_NN
of_IN
uremia_NN
are_VBP
not_RB
responsible_JJ
for_IN
the_DT
decrease_NN
in_IN
VDR_NN
concentration_NN
found_VBN
in_IN
these_DT
patients_NNS
._.

